231 related articles for article (PubMed ID: 33363204)
1. Systematic Analysis of Expression Profiles and Prognostic Significance for
Gan J; Li Y; Meng Q
Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
[No Abstract] [Full Text] [Related]
3. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
Zhang JT; Lin YC; Xiao BF; Yu BT
Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
[TBL] [Abstract][Full Text] [Related]
6. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.
Ma Z; Zhou Z; Zhuang H; Li Z; Ma Z; Huang B; Liu C; Gong Y; Zou Y; Zheng Z; Huang S; Zhang C; Hou B
Dis Markers; 2021; 2021():6682697. PubMed ID: 33747255
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
9. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
10. FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.
Richtmann S; Wilkens D; Warth A; Lasitschka F; Winter H; Christopoulos P; Herth FJF; Muley T; Meister M; Schneider MA
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31083571
[TBL] [Abstract][Full Text] [Related]
11. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
[TBL] [Abstract][Full Text] [Related]
12. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer.
Zheng X; Wang X; He Y; Ge H
Front Mol Biosci; 2022; 9():844618. PubMed ID: 35923467
[No Abstract] [Full Text] [Related]
14. Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma.
Liu X; Fu M; Xia D; Ji Z; Hu N; Leng Z; Xie W; Fang Y; Zhang J
J Oncol; 2022; 2022():8767333. PubMed ID: 36245969
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
Wang L; Feng X; Jiao Z; Gan J; Meng Q
Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
[TBL] [Abstract][Full Text] [Related]
16. Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
Luo J; Hu Q; Gou M; Liu X; Qin Y; Zhu J; Cai C; Tian T; Tu Z; Du Y; Deng H
Front Oncol; 2021; 11():680402. PubMed ID: 34660263
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
[TBL] [Abstract][Full Text] [Related]
18. The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms.
Fulcher LJ; Bozatzi P; Tachie-Menson T; Wu KZL; Cummins TD; Bufton JC; Pinkas DM; Dunbar K; Shrestha S; Wood NT; Weidlich S; Macartney TJ; Varghese J; Gourlay R; Campbell DG; Dingwell KS; Smith JC; Bullock AN; Sapkota GP
Sci Signal; 2018 May; 11(531):. PubMed ID: 29789297
[TBL] [Abstract][Full Text] [Related]
19. The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.
Bozatzi P; Sapkota GP
Biochem Soc Trans; 2018 Jun; 46(3):761-771. PubMed ID: 29871876
[TBL] [Abstract][Full Text] [Related]
20. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]